Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Anderson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 22, 2025
In-Hospital mortality in Spondylodiscitis: Risk factors assessed through the National Inpatient Sample analysisJulius Gerstmeyer, August Avantaggio, Clifford Pierre, et al.
Cancer Biology & Therapy|December 2, 2016
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab aloneKristian M Koller, Heath B Mackley, Jason Liu, et al.
Clinical Neurology and Neurosurgery|December 25, 2024
Incidence and predictors of readmission following hospitalization for thoracic disc herniationJulius Gerstmeyer, August Avantaggio, Anna Gorbacheva, et al.
Critical Reviews in Oncology/Hematology|September 18, 2016
Malignant melanoma-The cradle of anti-neoplastic immunotherapyKristian M Koller, Wenge Wang, Todd D Schell, et al.
Vaccine|September 17, 2018
Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosisAngela Toepp, Mandy Larson, Geneva Wilson, et al.
Parasites & Vectors|May 15, 2020
Predominant risk factors for tick-borne co-infections in hunting dogs from the USAKurayi Mahachi, Eric Kontowicz, Bryan Anderson, et al.
Molecular Cancer Therapeutics|November 21, 2019
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision MedicineShripad V Bhagwat, William T McMillen, Shufen Cai, et al.
Parasites & Vectors|January 25, 2019
Comorbid infections induce progression of visceral leishmaniasisAngela J Toepp, Glória R G Monteiro, José F V Coutinho, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 22, 2025
In-Hospital mortality in Spondylodiscitis: Risk factors assessed through the National Inpatient Sample analysisJulius Gerstmeyer, August Avantaggio, Clifford Pierre, et al.
Cancer Biology & Therapy|December 2, 2016
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab aloneKristian M Koller, Heath B Mackley, Jason Liu, et al.
Clinical Neurology and Neurosurgery|December 25, 2024
Incidence and predictors of readmission following hospitalization for thoracic disc herniationJulius Gerstmeyer, August Avantaggio, Anna Gorbacheva, et al.
Critical Reviews in Oncology/Hematology|September 18, 2016
Malignant melanoma-The cradle of anti-neoplastic immunotherapyKristian M Koller, Wenge Wang, Todd D Schell, et al.
Vaccine|September 17, 2018
Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosisAngela Toepp, Mandy Larson, Geneva Wilson, et al.
Parasites & Vectors|May 15, 2020
Predominant risk factors for tick-borne co-infections in hunting dogs from the USAKurayi Mahachi, Eric Kontowicz, Bryan Anderson, et al.
Molecular Cancer Therapeutics|November 21, 2019
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision MedicineShripad V Bhagwat, William T McMillen, Shufen Cai, et al.
Parasites & Vectors|January 25, 2019
Comorbid infections induce progression of visceral leishmaniasisAngela J Toepp, Glória R G Monteiro, José F V Coutinho, et al.
Pageof 3